English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Rice University engineers develop strategy to control peptide release from gelatin particles
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Review examines purinergic signaling's role in osteoarthritis progression and treatment options
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Studies identify CDC42 as key partner in pyrin-driven familial Mediterranean fever inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Biopharma job postings rise in Q2 2026 as layoffs decrease, report shows
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

Hyperfunction theory examined as influential framework in understanding human aging
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

Researchers use genetics and AI to identify potential osteoarthritis drug candidate
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Takeda’s Orzeyful for narcolepsy type 1 treatment
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

Industry leaders discuss differences between CROs and biotechs for career seekers

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes